Results 51 to 60 of about 5,742,584 (242)

Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. [PDF]

open access: yes, 2014
Adequate clinical and parasitologic cure by artemisinin combination therapies relies on the artemisinin component and the partner drug. Polymorphisms in the Plasmodium falciparum chloroquine resistance transporter (pfcrt) and P.
Kamugisha, Erasmus   +82 more
core   +1 more source

Worldwide Research Trends on Artemisinin: A Bibliometric Analysis From 2000 to 2021

open access: yesFrontiers in Medicine, 2022
ObjectiveArtemisinin is an organic compound that comes from Artemisia annua. Artemisinin treatment is the most important and effective method for treating malaria.
Yankai Dong   +14 more
doaj   +1 more source

Artemether resistance in vitro is linked to mutations in PfATP6 that also interact with mutations in PfMDR1 in travellers returning with Plasmodium falciparum infections. [PDF]

open access: yes, 2012
BACKGROUND: Monitoring resistance phenotypes for Plasmodium falciparum, using in vitro growth assays, and relating findings to parasite genotype has proved particularly challenging for the study of resistance to artemisinins.
Rosalba Lepore   +27 more
core   +1 more source

Functional analysis of Plasmodium falciparum subpopulations associated with artemisinin resistance in Cambodia

open access: yesMalaria Journal, 2017
Background Plasmodium falciparum malaria is one of the most widespread parasitic infections in humans and remains a leading global health concern. Malaria elimination efforts are threatened by the emergence and spread of resistance to artemisinin-based ...
Ankit Dwivedi   +12 more
doaj   +1 more source

Mapping genetic markers of artemisinin resistance in Plasmodium falciparum malaria in Asia: a systematic review and spatiotemporal analysis

open access: yesThe Lancet Microbe, 2022
Summary Background The increase in artemisinin resistance threatens malaria elimination in Asia by the target date of 2030 and could derail control efforts in other endemic regions.
F. Kagoro   +9 more
semanticscholar   +1 more source

Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda. [PDF]

open access: yes, 2005
BACKGROUND: Drug resistance in Plasmodium falciparum poses a major threat to malaria control. Combination antimalarial therapy including artemisinins has been advocated recently to improve efficacy and limit the spread of resistance, but artemisinins are
Albert Kilian   +59 more
core   +2 more sources

Identifying artemisinin resistance from parasite clearance half-life data with a simple Shiny web application. [PDF]

open access: yesPLoS ONE, 2017
The emergence of artemisinin-resistant Plasmodium falciparum malaria is a major threat to malaria elimination. New tools for supporting the surveillance of artemisinin resistance are critical for current and future malaria control and elimination ...
Sai Thein Than Tun   +8 more
doaj   +1 more source

In Vitro Confirmation of Artemisinin Resistance in Plasmodium falciparum from Patient Isolates, Southern Rwanda, 2019

open access: yesEmerging Infectious Diseases, 2022
Artemisinin resistance in Plasmodium falciparum is conferred by mutations in the kelch 13 (K13) gene. In Rwanda, K13 mutations have increased over the past decade, including mutations associated with delayed parasite clearance.
Welmoed van Loon   +7 more
semanticscholar   +1 more source

Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda. [PDF]

open access: yes, 2006
OBJECTIVES: To compare the efficacy and safety of artemisinin combination therapies for the treatment of uncomplicated falciparum malaria in Uganda. DESIGN: Randomized single-blind controlled trial.
Staedke Sarah G   +21 more
core   +1 more source

Short tandem repeat polymorphism in the promoter region of cyclophilin 19B drives its transcriptional upregulation and contributes to drug resistance in the malaria parasite Plasmodium falciparum.

open access: yesPLoS Pathogens, 2023
Resistance of the human malaria parasites, Plasmodium falciparum, to artemisinins is now fully established in Southeast Asia and is gradually emerging in Sub-Saharan Africa.
Michal Kucharski   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy